AAAAAA

   
Results: 1-9 |
Results: 9
THE EFFECTS OF LOW-DOSE TESTOSTERONE TREATMENT ON LIPID-METABOLISM, CLOTTING FACTORS AND ULTRASONOGRAPHIC OVARIAN MORPHOLOGY IN WOMEN
Authors: BUCKLER HM MCELHONE K DURRINGTON PN MACKNESS MI LUDLAM CA WU FCW
Citation: Hm. Buckler et al., THE EFFECTS OF LOW-DOSE TESTOSTERONE TREATMENT ON LIPID-METABOLISM, CLOTTING FACTORS AND ULTRASONOGRAPHIC OVARIAN MORPHOLOGY IN WOMEN, Clinical endocrinology, 49(2), 1998, pp. 173-178
LOW-DOSE, ALTERNATE-DAY RECOMBINANT FSH IN AN OVULATION INDUCTION-PROGRAM
Authors: BUCKLER HM LAMBERT A ANDERSON A ROBERTSON WR
Citation: Hm. Buckler et al., LOW-DOSE, ALTERNATE-DAY RECOMBINANT FSH IN AN OVULATION INDUCTION-PROGRAM, Human reproduction (Oxford. Print), 13, 1998, pp. 138-138
WHICH ANDROGEN REPLACEMENT THERAPY FOR WOMEN
Authors: BUCKLER HM ROBERTSON WR WU FCW
Citation: Hm. Buckler et al., WHICH ANDROGEN REPLACEMENT THERAPY FOR WOMEN, The Journal of clinical endocrinology and metabolism, 83(11), 1998, pp. 3920-3924
EVALUATION OF ADVERSE EXPERIENCES RELATED TO PAMIDRONATE INFUSION IN PAGETS-DISEASE OF BONE
Authors: BUCKLER HM MERCER SJ DAVISON CE HOLLIS S RICHARDSON PC ANDERSON DC
Citation: Hm. Buckler et al., EVALUATION OF ADVERSE EXPERIENCES RELATED TO PAMIDRONATE INFUSION IN PAGETS-DISEASE OF BONE, Annals of the Rheumatic Diseases, 57(9), 1998, pp. 572-572
ESTRADIOL AND IMMUNOREACTIVE INHIBIN-LIKE SECRETORY PATTERNS FOLLOWING CONTROLLED OVARIAN HYPERSTIMULATION WITH URINARY (METRODIN) OR RECOMBINANT FOLLICLE-STIMULATING-HORMONE (PUREGON)
Authors: MITCHELL R BUCKLER HM MATSON P LIEBERMAN B BURGER HG HILTON B HORNE G DYSON M ROBERTSON WR
Citation: R. Mitchell et al., ESTRADIOL AND IMMUNOREACTIVE INHIBIN-LIKE SECRETORY PATTERNS FOLLOWING CONTROLLED OVARIAN HYPERSTIMULATION WITH URINARY (METRODIN) OR RECOMBINANT FOLLICLE-STIMULATING-HORMONE (PUREGON), Human reproduction, 11(5), 1996, pp. 962-967
AN AUDIT OF ESTRADIOL LEVELS AND IMPLANT FREQUENCY IN WOMEN UNDERGOING SUBCUTANEOUS IMPLANT THERAPY
Authors: BUCKLER HM KALSI PK CANTRILL JA ANDERSON DC
Citation: Hm. Buckler et al., AN AUDIT OF ESTRADIOL LEVELS AND IMPLANT FREQUENCY IN WOMEN UNDERGOING SUBCUTANEOUS IMPLANT THERAPY, Clinical endocrinology, 42(5), 1995, pp. 445-450
INTRAVENOUS PAMIDRONATE - EVOLUTION OF AN EFFECTIVE TREATMENT STRATEGY
Authors: ANDERSON DC RICHARDSON PC BROWN JK FREEMONT AJ HOLLIS S DENTON J BUCKLER HM HARGREAVES S CANTRILL JA
Citation: Dc. Anderson et al., INTRAVENOUS PAMIDRONATE - EVOLUTION OF AN EFFECTIVE TREATMENT STRATEGY, Seminars in arthritis and rheumatism, 23(4), 1994, pp. 273-275
DOES GONADOTROPIN SUPPRESSION RESULT IN FOLLICULAR DEVELOPMENT IN PREMATURE OVARIAN FAILURE
Authors: BUCKLER HM HEALY DL BURGER HG
Citation: Hm. Buckler et al., DOES GONADOTROPIN SUPPRESSION RESULT IN FOLLICULAR DEVELOPMENT IN PREMATURE OVARIAN FAILURE, Gynecological endocrinology, 7(2), 1993, pp. 123-128
PHYSIOLOGICAL ESTRADIOL ADMINISTRATION DOES NOT CHANGE THE BIOLOGICALTO IMMUNOLOGICAL RATIO OF LH IN SERUM FROM POSTMENOPAUSAL WOMEN
Authors: BUCKLER HM ROTHWELL C HOLLIS S ROBERTSON WR
Citation: Hm. Buckler et al., PHYSIOLOGICAL ESTRADIOL ADMINISTRATION DOES NOT CHANGE THE BIOLOGICALTO IMMUNOLOGICAL RATIO OF LH IN SERUM FROM POSTMENOPAUSAL WOMEN, Clinical endocrinology, 38(5), 1993, pp. 481-485
Risultati: 1-9 |